1
Michelle LeRoux Williams, Charles Randal Mills, Rodney Monroy: Cancellous bone treated with collagenase and essentially free of blood cells. NuVasive, NuVasive, Jonathan Spangler, Jennifer Russell, June 11, 2013: US08460860 (2 worldwide citation)

A bone implant comprising cancellous bone that is essentially free of blood cells, and which has been treated with at least a loosening agent, such as collagenase and/or a digestive enzyme, for a time and at a concentration to loosen the osteogenic cells in the cancellous bone matrix. The osteogenic ...


2
Michelle LeRoux Williams, Charles Randal Mills, Rodney Monroy: Cancellous bone treated with collagenase and essentially free of blood cells. Raymond J Lillie Esq, c o Carella Byrne Bain Gilfillan, November 8, 2007: US20070260326-A1

A bone implant comprising cancellous bone that is essentially free of blood cells, and which has been treated with at least a loosening agent, such as collagenase and/or a digestive enzyme, for a time and at a concentration to loosen the osteogenic cells in the cancellous bone matrix. The osteogenic ...


3
Timothy Varney, Charles Randal Mills, Alla Danilkovitch: Use of mesenchymal stem cells for treating genetic diseases and disorders. Osiris Therapeutics, Raymond J Lillie Eq, c o Carella Byrne Bain Gilfillan Cecchi, November 1, 2007: US20070253931-A1

A method of treating a genetic disease or disorder such as, for example, cystic fibrosis, Wilson's disease, amyotrophic lateral sclerosis, or polycystic kidney disease, in an animal comprising administering to said animal mesenchymal stem cells in an amount effective to treat the genetic disease or ...


4
Michelle LeRoux Williams, Charles Randal Mills, Rodney Monroy, Robert A Zambon, Dayna Buskirk, Earl Fender: Cancellous bone treated with collagenase and essentially free of blood cells. Raymond J Lillie Esq, c o Carella Byrne Bain Gilfillan, October 23, 2008: US20080262633-A1

A bone implant comprising cancellous bone that is essentially free of blood cells, and which has been treated with at least one loosening agent, such as collagenase or a digestive enzyme, for a time and at a concentration to loosen the osteogenic cells in the cancellous bone matrix. The osteogenic c ...


5
Timothy R Varney, Charles Randal Mills, Alla Danilkovitch: Use of mesenchymal stem cells for treating genetic diseases and disorders. Mcandrews Held & Malloy, November 20, 2008: US20080286249-A1

A method of treating a genetic disease or disorder such as, for example, cystic fibrosis, Wilson's disease, amyotrophic lateral sclerosis, or polycystic kidney disease, in an animal comprising administering to said animal mesenchymal stem cells in an amount effective to treat the genetic disease or ...


6
Timothy R Varney, Charles Randal Mills, Alla Danilkovitch: Use of Mesenchymal Stem Cells for Treating Genetic Disease and Disorders. Mcandrews Held & Malloy, November 18, 2010: US20100291047-A1

A method of treating a genetic disease or disorder such as, for example, cystic fibrosis, Wilson's disease, amyotrophic lateral sclerosis, or polycystic kidney disease, in an animal comprising administering to said animal mesenchymal stem cells in an amount effective to treat the genetic disease or ...


7
Timothy R Varney, Charles Randal Mills, Alla Danilkovitch: Use of Mesenchymal Stem Cells for Treating Genetic Diseases and Disorders. Mcandrews Held & Malloy, December 30, 2010: US20100330052-A1

A method of treating a genetic disease or disorder such as, for example, cystic fibrosis, Wilson's disease, amyotrophic lateral sclerosis, or polycystic kidney disease, in an animal comprising administering to said animal mesenchymal stem cells in an amount effective to treat the genetic disease or ...


8
Timothy Varney, Charles Randal Mills, Alla Danilkovitch: Use of mesenchymal stem cells for treating genetic diseases and disorders. Mcandrews Held & Malloy, April 22, 2010: US20100098672-A1

A method of treating a genetic disease or disorder such as, for example, cystic fibrosis, Wilson's disease, amyotrophic lateral sclerosis, or polycystic kidney disease, in an animal comprising administering to said animal mesenchymal stem cells in an amount effective to treat the genetic disease or ...


9
Timothy R Varney, Charles Randal Mills, Alla Danilkovitch: Use of Mesenchymal Stem Cells for Treating Genetic Disease and Disorders. July 21, 2011: US20110177045-A1

A method of treating a genetic disease or disorder such as, for example, cystic fibrosis, Wilson's disease, amyotrophic lateral sclerosis, or polycystic kidney disease, in an animal comprising administering to said animal mesenchymal stem cells in an amount effective to treat the genetic disease or ...


10
Timothy Varney, Charles Randal Mills, Alla Danilkovitch: Use of mesenchymal stem cells for treating genetic diseases and disorders. December 15, 2011: US20110305678-A1

A method of treating a genetic disease or disorder such as, for example, cystic fibrosis, Wilson's disease, amyotrophic lateral sclerosis, or polycystic kidney disease, in an animal comprising administering to said animal mesenchymal stem cells in an amount effective to treat the genetic disease or ...